Catalyst Wire Dossier Catalyst Wire Dossier

esmirtazapine (Org 50081)

esmirtazapine · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for esmirtazapine (Org 50081), covering 2014-08-06 to 2014-08-06. Get the full timeline:

Most recent: Clinical Trial Update: A Six Week, Double-Blind Randomized, Efficacy and Safety, Sleep Lab Trial With Esmirtazapine (Org 50081) (P05707) [Phase 3]

See pricing